Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Patient Care
Surgical & Supplies
Return to: MDBR Home | Patient Care | Surgical & Supplies

Femasys signs distribution agreement with McKesson Medical-Surgical for FemCerv device for diagnosis of cervical cancer

Published 09 July 2014

Femasys Inc., an emerging medical device developer of women's healthcare solutions, announced today that it has entered into a nationwide distribution agreement with McKesson Medical-Surgical to sell and distribute Femasys' FEMCERV Endocervical Sampler. FEMCERV collects a tissue sample of a woman's endocervical canal for histological analysis when cervical cancer is suspected.

Under terms of the agreement, McKesson Medical-Surgical will sell and distribute the FEMCERV device nationwide through its sales force. Kathy Lee-Sepsick, President & CEO of Femasys commented, "We are thrilled to create an alliance with McKesson Medical-Surgical in bringing FEMCERV to the market as a novel new advancement in tissue sample collection for cervical cancer diagnosis. With McKesson Medical-Surgical's extensive market presence, physicians will gain access across the country to this much needed technology that has been designed with the woman and her anatomy in mind. Clinical data has demonstrated that physicians find FEMCERV easy to insert and well tolerated by almost all patients, who experienced mild or no discomfort."

"We're pleased to offer Femasys' FEMCERV product to our customers," said Joan Eliasek, Senior Vice President, Supplier Management, McKesson Medical-Surgical. "As a company, we are in business for one reason: better health. And fighting cancer is a major aspect of better health in our country. We are glad to offer products to our customers that help them deliver better care for their patients."

Source: Company Press Release